Skip to main content
Contact Us
Subscribe
E-Edition
64°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
469.76
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
107
Open
469.76
Bid (Size)
457.00 (2)
Ask (Size)
479.32 (1)
Prev. Close
469.76
Today's Range
469.76 - 469.76
52wk Range
341.85 - 510.63
Shares Outstanding
259,428,394
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
What Analysts Are Saying About Vertex Pharmaceuticals Stock
October 01, 2024
Via
Benzinga
Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit.
September 26, 2024
Pfizer stock dipped Thursday after the company voluntarily pulled its sickle cell drug, Oxbryta, from the market following patient deaths.
Via
Investor's Business Daily
Performance
YTD
+14.32%
+14.32%
1 Month
-1.25%
-1.25%
3 Month
-0.85%
-0.85%
6 Month
+14.74%
+14.74%
1 Year
+35.03%
+35.03%
More News
Read More
Vertex Highlights First Oral Presentation of Phase 3 Clinical Data of the Vanza Triple and New Data on Long-Term Impact of TRIKAFTA® at the North American Cystic Fibrosis Conference
September 26, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,200 Today
September 25, 2024
Via
Benzinga
Demystifying Vertex Pharmaceuticals: Insights From 16 Analyst Reviews
September 19, 2024
Via
Benzinga
Looking Into Vertex Pharmaceuticals's Recent Short Interest
September 18, 2024
Via
Benzinga
Vertex Pharmaceuticals's Options Frenzy: What You Need to Know
August 29, 2024
Via
Benzinga
The Best Biotech Stock to Invest $1,000 in Right Now
September 22, 2024
Via
The Motley Fool
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
September 21, 2024
Via
The Motley Fool
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
September 18, 2024
Via
The Motley Fool
3 Stocks to Buy and Hold Forever
September 14, 2024
Via
The Motley Fool
Prediction: These 3 Phenomenal Stocks Are Set to Soar
September 14, 2024
Via
The Motley Fool
Time To Invest And Or Trade In Bio-Tech Stocks?
September 13, 2024
Via
Talk Markets
Topics
ETFs
Looking Into Vertex Pharmaceuticals's Recent Short Interest
August 27, 2024
Via
Benzinga
Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals
August 23, 2024
Via
Benzinga
Biotech Breakout: Stocks for Your Watchlist
September 12, 2024
Via
MarketBeat
Topics
ETFs
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years
September 06, 2024
Via
Benzinga
3 No-Brainer Stocks to Buy in September
August 31, 2024
Via
The Motley Fool
3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever
August 30, 2024
Via
The Motley Fool
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
August 30, 2024
Via
The Motley Fool
If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,900 Today
August 21, 2024
Via
Benzinga
Biotech And Life Science Sector Update Summer Of 2024
August 29, 2024
Via
Talk Markets
Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics
August 29, 2024
Via
Benzinga
Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead
August 23, 2024
Via
The Motley Fool
Vertex to Participate in Upcoming September Investor Conferences
August 22, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.